Legal & General Group
GSK icon

Legal & General Group’s GSK GSK Stock Holding History

Legal & General Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,200
Closed -$226K – 3293
2016
Q3 		$226K Hold
4,200
– – ﹤0.01% 1997
2016
Q2 		$228K Hold
4,200
– – ﹤0.01% 1727
2016
Q1 		$213K Hold
4,200
– – ﹤0.01% 1718
2015
Q4 		$212K Hold
4,200
– – ﹤0.01% 1721
2015
Q3 		$202K Hold
4,200
– – ﹤0.01% 1702
2015
Q2 		$219K Buy
+4,200
New +$236K ﹤0.01% 1705

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legal & General Group's GSK Position: Q4 2016 in Review

Legal & General Group sold out of GSK (GSK) in Q4 2016, closing a stake of 4,200 shares — an estimated $226K sold.

Legal & General Group first reported a position in GSK in Q2 2015 and held it in 6 quarters. The position peaked at $228K in Q2 2016. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Legal & General Group reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Legal & General Group sold 4,200 GSK shares in Q4 2016, an estimated $226K.
  • Legal & General Group first reported a position in GSK in Q2 2015 and held it in 6 quarters.
  • Legal & General Group's GSK position peaked at $228K in Q2 2016.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Legal & General Group's 13F filing for Q4 2016, filed 13 Feb 2017.